Ignite Creation Date:
2025-12-24 @ 11:28 PM
Ignite Modification Date:
2025-12-29 @ 11:30 PM
Study NCT ID:
NCT04200456
Status:
TERMINATED
Last Update Posted:
2025-03-18
First Post:
2019-12-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)
Sponsor:
UCB Biopharma SRL
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-01-31
Start Date Type:
ACTUAL
Primary Completion Date:
2022-03-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-04-27
Completion Date Type:
ACTUAL
First Submit Date:
2019-12-13
First Submit QC Date:
None
Study First Post Date:
2019-12-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-05-15
Results First Submit QC Date:
None
Results First Post Date:
2023-08-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2023-08-08
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-03-06
Last Update Post Date:
2025-03-18
Last Update Post Date Type:
ACTUAL